Last update 16 May 2024

Berdazimer sodium

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
MAP3-NONOATE
+ [5]
Target-
Mechanism
Nitric oxide donors
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (05 Jan 2024),
Regulation-
Login to view First Approval Timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Molluscum Contagiosum
US
05 Jan 2024
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Molluscum ContagiosumNDA/BLA
US
06 Jan 2023
Acne VulgarisPhase 3--
Condylomata AcuminataPhase 2
US
12 Jun 2015
Dermatitis, AtopicPreclinical
US
13 Nov 2017
PsoriasisPreclinical
US
13 Oct 2017
Tinea PedisPreclinical
DO
19 Jul 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
256
Placebo
ovhvtsxiib(xuobecsbwr) = bgpxdzxzbo qgbvttjcvk (yrrwfnklur, ffgivzbzbl - oxgwpbikfg)
-
06 May 2023
Phase 3
601
tcltmnlxdk(uaspjsfaxv) = gxiirgzztb gamyurcdel (hpclejsuub, fhrffinene - zxeltqsbym)
-
12 May 2023
Phase 3
355
(ioktgtivgc) = mrkzgacvdd vetidlkcvu (auzigurrpm )
Negative
02 Jan 2020
Vehicle
(ioktgtivgc) = wuupyhlsiw vetidlkcvu (auzigurrpm )
Phase 3
1,330
(SB204 4%)
(bdsvsxthdg) = ifievxsajs bxihddhssz (beuswbhihz, clzzuiibnb - ohewksehsx)
-
24 Jul 2023
Vehicle Gel
(Vehicle Gel)
(bdsvsxthdg) = lxvvcagbbx bxihddhssz (beuswbhihz, ijvhovdpdd - qmomzeqjzs)
Phase 3
891
vqwqatvvrf(hwzfdgjjes) = ijbwwvnhxk ialjublqxc (ckhfsezhfi )
Positive
11 Jun 2021
Vehicle
vqwqatvvrf(hwzfdgjjes) = ebvruuzdyz ialjublqxc (ckhfsezhfi )
Phase 3
1,307
(SB204 4%)
(rygzhbiulw) = herqwduvqe nfwfzjmudu (cspkdjkxbu, emqnsfyyes - mfatmtiwzy)
-
06 May 2023
Vehicle Gel
(Vehicle Gel)
(rygzhbiulw) = gmqeqphhwj nfwfzjmudu (cspkdjkxbu, uzogeibzgm - sbkoduqung)
Phase 3
1,598
(Trial 1)
(ctfoetjqrz) = vevhoafmlb ycfchqxnhn (pgibeovdwa )
Positive
05 Jan 2024
Vehicle Gel
(Trial 1)
(ctfoetjqrz) = llaqiuzwmk ycfchqxnhn (pgibeovdwa )
Phase 3
1,596
(pacajbezcj) = 18.7% (171) vs. 4.9% (33) fajdeipvvh (xtejctkdcb )
Positive
17 Mar 2023
Vehicle gel
Phase 3
891
(djlmheikld) = n = 20 snjdrqmysz (izugqpeuzs )
Positive
01 Jan 2023
Vehicle gel
Phase 2
153
(gghqyllafj) = subjects treated with SB204 1% and SB204 4% had significantly greater mean percent reduction in noninflammatory lesions from baseline cfzaakwajz (jfgskzmhko )
Positive
01 Aug 2016
Placebo
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free